EUVIMEDEUVIMED entdecken
Multizentrische Studie

Receiving Abortion Medication Through Mail Was Safe, Effective

Emily Harris

JAMA · 2024

DOI: 10.1001/jama.2024.10330 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA, 2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Abortifacient Agents, Abortion, Induced, Mifepristone, Misoprostol.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Daniel Grossman, MD; Sarah Raifman, MSc; Natalie Morris, MPH; Andrea Arena, MD; Lela Bachrach, MD; Jessica Beaman, MD; M. Antonia Biggs, PhD; Amy Collins, MD, MS; Curtiss Hannum, CRNP; Stephanie Ho, MD; Susan M. Seibold-Simpson, PhD, MPH, RN; Mindy Sobota, MD, MS, MPhil; Kristina Tocce, MD, MPH; Eleanor B. Schwarz, MD; Marji Gold, MD

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Abortifacient AgentsAbortion, InducedMifepristoneMisoprostolPostal ServiceAdolescentAdultFemaleHumansPregnancyYoung AdultPharmaceutical ServicesUnited StatesTreatment Outcome

Substanzen

Abortifacient AgentsMifepristoneMisoprostol

Zitieren

APA

Harris, E. (2024). Receiving Abortion Medication Through Mail Was Safe, Effective. JAMA. https://doi.org/10.1001/jama.2024.10330

Vancouver

Harris E. Receiving Abortion Medication Through Mail Was Safe, Effective. JAMA. 2024. doi:10.1001/jama.2024.10330

BibTeX
@article{Harris2024,
  author = {Harris, Emily},
  title = {Receiving Abortion Medication Through Mail Was Safe, Effective},
  journal = {JAMA},
  year = {2024},
  doi = {10.1001/jama.2024.10330}
}
Kostenlos starten →